photo of

Details

Role Group Leader / Honorary Fellow Manager
Research area Infection, Immunity and Global Health
Group Molecular Microbiology
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.

Top Publications

  • Garland, SM, Cornall, AM, Brotherton, JML, Wark, JD, Malloy, MJ, Tabrizi, SN, group, OBOTVS. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program. Vaccine 36(23) : 3221 -3230 2018
    view publication
  • Callegari, ET, Garland, SM, Gorelik, A, Chiang, CY, Wark, JD. Bone turnover marker determinants in young women: results from the Safe-D study. Annals of Clinical Biochemistry International Journal of Laboratory Medicine 55(3) : 328 -340 2018
    view publication
  • Machalek, DA, Garland, SM, Brotherton, JML, Bateson, D, McNamee, K, Stewart, M, Rachel Skinner, S, Liu, B, Cornall, AM, Kaldor, JM, et al. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination.. The Journal of Infectious Diseases 217(10) : 1590 -1600 2018
    view publication
  • Varanasi, LC, Subasinghe, A, Jayasinghe, YL, Callegari, ET, Garland, SM, Gorelik, A, Wark, JD. Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16–29 years. Australian and New Zealand Journal of Obstetrics and Gynaecology 58(2) : 222 -233 2018
    view publication
  • Read, TRH, Jensen, JS, Fairley, CK, Grant, M, Danielewski, JA, Su, J, Murray, GL, Chow, EPF, Worthington, K, Garland, SM, et al. Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection - Volume 24, Number 2—February 2018 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 24(2) : 328 -335 2018
    view publication

Page 39 of 147

Related links